Acute myeloid leukemia (AML) is cancer that initiates inside bone marrow and affects the whole blood. Acute myeloid leukemia (AML) is not just a single disease but a group of leukemias that develops ...
A highly sensitive test that detects traces of disease in the bone marrow of patients with a rare and aggressive type of blood cancer could help double their chances of survival, a new trial has found ...
The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted therapies, the promise of off-the-shelf chimeric antigen receptor (CAR) ...
Errata: Environmental Impact Assessment of Intravenous Versus Subcutaneous Monoclonal Antibodies: A Carbon Footprint Analysis The classification of AML and therapeutic options are now largely driven ...
Researchers at the National Institutes of Health show the benefits of screening adult patients in remission from acute myeloid leukemia (AML) for residual disease before receiving a bone marrow ...
In recent years, a drug called venetoclax has become a key part of treatment for AML. Approved in 2019, venetoclax is often ...
Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback